Navigation Links
Proteolix Announces New Appointment in Finance and Expands Clinical and Regulatory Leadership Team
Date:4/16/2009

SOUTH SAN FRANCISCO, Calif., April 16 /PRNewswire/ -- Proteolix, Inc. today announced the appointment of Craig C. Parker to the post of Senior Vice President, Finance and Corporate Development and Chief Financial Officer (CFO), and the expansion of the company's clinical development and regulatory leadership team with the appointment of Michael G. Kauffman, M.D., Ph.D., to the post of Chief Medical Officer (CMO) and Albert L. Kraus, Ph.D., to the newly-created position of Vice President, Regulatory Affairs and Quality Assurance.

"We are pleased to welcome Craig Parker and Drs. Kauffman and Kraus to the Proteolix team at this important stage in the company's maturation. Craig's rich experience in finance, management and forming partnerships make him a superb addition as we advance our lead anti-cancer product, carfilzomib, into late-stage clinical studies," said John A. Scarlett, M.D., Proteolix's President and Chief Executive Officer. "In addition, the expansion of our clinical development leadership team reflects the excellent progress made in carfilzomib's development. Michael's background as program leader in the development of VELCADE, combined with his knowledge of carfilzomib as a prior member of the Proteolix Board of Directors, and Albert's experience in regulatory affairs and shepherding the late-stage development of new oncology therapeutics, will be invaluable as Proteolix advances carfilzomib through pivotal clinical trials."

Craig C. Parker

Senior Vice President, Finance and Corporate Development and Chief Financial Officer

Mr. Parker brings more than 15 years of finance and business development leadership in the biotechnology industry to Proteolix. In this newly-created role, he is responsible for the company's financial operations, business development, corporate strategic planning and legal affairs.

Mr. Parker's career includes 12 years as a Wall Street resear
'/>"/>

SOURCE Proteolix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Proteolixs Carfilzomib Receives Orphan Drug Designation for Treatment of Multiple Myeloma
3. Proteolix Raises $79 Million in Series C Financing
4. Proteolix Presents Preclinical Data for Oral Proteasome Inhibitor PR-047 at the 50th Annual Meeting of the American Society of Hematology
5. Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...2 S*BIO Pte Ltd today announced da... SB1518, at The American Society of Hematology 51s..., Data will be presented on the clinical results...detailing its safety, tolerability and pharmacokin...s ranging from 100 to 600 mg. These doses were adm...
(Date:12/2/2009)... Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutica...), a leading pharmaceutical company,specializing i... branded,generic and proprietary pharmaceuticals i...e been included in China,s National Drug Reimburse...nistry of Human Resources and Social,Security on N...
(Date:12/2/2009)...2 /PRNewswire-Asia/ -- The world is going through,...certainty is part of many,businesses and industrie...relatively immune to the economic downturn, becaus...ng the midst of the difficult times this year, the...rated an R&D center in Shanghai, the largest o...
(Date:12/2/2009)... According to the National Institu...s diagnosed with diabetes already have some stage ...mage to the retina caused by leaky blood vessels, ...tes and is one of the most feared diabetic complic... who,ve had diabetes for 10 years or more will exp...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
...ecuring venture investments, commercializing techn...ng innovative companies in Wisconsin will not read...into federal government dollars. , ,This is the p...reated by a collaboration between the Wisconsin lo...e national economic development agency GSP Consul...
... Building the Merge Healthcare of tomorrow, as c...will mean offshoring 150 jobs to a "more cost effe...8 percent of the financially troubled medical imag...tes, Canada, and Japan to regain the competitive e...ion initiative euphemistically labeled rightsizing...
...a natural biological response to the phrase securi...opaque film over the outside of the cornea wall, c... avoid this, I will do my best to stick to the ess... from comprehensive. So if your company is raising...ho is familiar with securities laws early so that ...
Other Biology Technology:New firm to help companies land federal dollars 2Merge offshoring jobs to "more cost-effective" workforce 2Merge offshoring jobs to "more cost-effective" workforce 3Securities compliance is part of raising capital 2Securities compliance is part of raising capital 3Securities compliance is part of raising capital 4
(Date:12/2/2009)...ur muscles can twitch, before the thought telling ...ate of sortscalled an ion channelmust open in the ... chemical signals that spur the cell to action. Ne... and Technology (NIST) has allowed scientists to o...r the first time, potentially offering insights fo...
(Date:12/2/2009)... the University of Salamanca and another from Yale...ors affects the behaviour of Acanthodactylus beer... in the Near East. According to the study, these r...ent prey if they are under pressure from predators...esult, but until now there had been very few exper...
(Date:12/1/2009)...ants have two different feeding strategies. A lar...aning that they are generalist predators feeding o...ns. Some, however, are "herbivorous". This is no...lk of their diets consist of plant-derived matter....d by plants to attract ants, called extra-floral n...
Breaking Biology News(10 mins):Nervy research: Researchers take initial look at ion channels in a model system 2Lizards change their diet to avoid predators 2Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants 2NIH researchers identify key factor that stimulates brain cancer cells to spread 54768 1NIH researchers identify key factor that stimulates brain cancer cells to spread 54768 2NIH researchers identify key factor that stimulates brain cancer cells to spread 54768 3 26quot 3BMed Records to Go 26quot 3B Stores Document and Image Files of Medical Facilities for Emergency Viewing 54765 1 26quot 3BMed Records to Go 26quot 3B Stores Document and Image Files of Medical Facilities for Emergency Viewing 54765 2 26quot 3BMed Records to Go 26quot 3B Stores Document and Image Files of Medical Facilities for Emergency Viewing 54765 3Medicare Picks N J to Test Innovative Incentive System 54762 1Medicare Picks N J to Test Innovative Incentive System 54762 2Medicare Picks N J to Test Innovative Incentive System 54762 3Medicare Picks N J to Test Innovative Incentive System 54762 4
...ression, researchers have found that variation in ...e with age. The findings, which impact our underst...ated changes, are reported in the May 23rd issue o...t the Max Planck Institute for Evolutionary Anthro...g-standing observation concerning the physiologica...
...e autistic brain has fewer neurons in an area rela... new study published in the July 19 issue of The ...quantitative evidence linking autism to an abnorma...us—a major emotion-processing area with connection...nitive functions. , "These new findings, based...
...n and Australian researchers announced June 20, 20...he way people respond to HIV. , Through the new co...vestigators who once competed to unravel the myste...alled cohorts, they have studied. , Support for t...DS Vaccine Immunology (CHAVI), established at Duke...
Other Biology News:Gene expression becomes heterogeneous with age in humans and rats 2Autistic brain has fewer neurons for processing emotion 2CHAVI announces international search for genes affecting HIV response 2CHAVI announces international search for genes affecting HIV response 3
Illumina Custom Data Analysis Report from Asuragen, Inc.
DKW/Juglans Basal Salt Mixture from Sigma-Aldrich
BD Falcon Roller Bottle, smooth surface from BD Biosciences - Discovery Labware
...convenient method for the rapid, thorough lysis of...ith S. cerevisiae and C. albicans but can be used ...t lytic enzyme digestion. The Zymolyase digestion ...ast cells that are ideal for both protein and DNA ...
Biology Products: